drugset / Trial / NCT00518245
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether enoxaparin (an anticoagulant) is effective in the treatment of patients presenting to the emergency room with chest pain and no electrocardiogram or bloodwork evidence of a heart attack, but with other high risk clinical features
Timeline
- Start
- 2007-08
- Primary completion
- 2009-03
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 1 mg/kg | Subcutaneous |